SCHEMBL7981263

SCHEMBL7981263

CC(=O)C12CCN(CC1)C2

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.40
CHRM4 P08173 2/20 0.40
CHRM1 P11229 2/20 0.40
CHRM3 P20309 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8557075 0.91 CHRM2 (0.46) CHRM2CHRM4CHRM1CHRM3
SCHEMBL9444180 0.84 CHRM2 (0.31) CHRM2CHRM4CHRM1CHRM3
SCHEMBL2556850 0.77 CHRM2 (0.37) CHRM2CHRM4CHRM1CHRM3
SCHEMBL8523645 0.76 CHRM2 (0.38) CHRM2CHRM4CHRM1CHRM3
SCHEMBL206768 0.75 CHRM2 (0.36) CHRM2CHRM4CHRM1CHRM3
Hydrochloric Acid SCHEMBL4198612 0.75 CHRM2 (0.36) CHRM2CHRM4CHRM1CHRM3
SCHEMBL9050123 0.75 CHRM2 (0.36) CHRM2CHRM4CHRM1CHRM3
SCHEMBL14351404 0.75 CHRM2 (0.36) CHRM2CHRM4CHRM1CHRM3
SCHEMBL24663500 0.75 CHRM2 (0.37) CHRM2CHRM4CHRM1CHRM3
SCHEMBL3318136 0.75 CHRM2 (0.44) CHRM2CHRM4CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001014310-A1 PLEUROMUTILIN β-KETOESTERS SMITHKLINE BEECHAM P.L.C. (GB) 2001-03-01 WO disclosed
EP-0366304-B1 Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1998-04-15 EP disclosed
EP-0338723-B1 NOVEL COMPOUNDS BEECHAM GROUP PLC (GB) 1993-08-04 EP disclosed
US-5217975-A AZABICYCLIC COMPOUNDS FOR TREATING DEMENTIA BEECHAM GROUP P.L.C. (GB) 1993-06-08 US disclosed
US-5166357-A Nitrogen heterocylic compounds used in treatment of dementia in mammals BEECHAM GROUP P.L.C. (GB) 1992-11-24 US disclosed
US-5110828-A Treatment or prophylaxis of dementia BEECHAM GROUP P.L.C. (GB) 1992-05-05 US disclosed
EP-0402056-A2 Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them Beecham Group p.l.c. (GB) 1990-12-12 EP disclosed
EP-0366304-A2 Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1990-05-02 EP disclosed
EP-0338723-A1 Novel compounds BEECHAM GROUP PLC (GB) 1989-10-25 EP disclosed